Gambling, Resorts & Casinos
Compare Stocks
5 / 10Stock Comparison
BYD vs PEN vs ISRG vs CZR vs SYK
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Devices
Medical - Instruments & Supplies
Gambling, Resorts & Casinos
Medical - Devices
BYD vs PEN vs ISRG vs CZR vs SYK — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Gambling, Resorts & Casinos | Medical - Devices | Medical - Instruments & Supplies | Gambling, Resorts & Casinos | Medical - Devices |
| Market Cap | $6.42B | $12.77B | $161.07B | $5.66B | $112.69B |
| Revenue (TTM) | $4.09B | $1.45B | $10.58B | $11.56B | $25.12B |
| Net Income (TTM) | $1.84B | $171M | $2.98B | $-485M | $3.25B |
| Gross Margin | 42.1% | 67.4% | 66.3% | 43.9% | 63.5% |
| Operating Margin | 21.4% | 12.9% | 30.5% | 17.8% | 22.4% |
| Forward P/E | 11.9x | 65.2x | 43.3x | — | 19.6x |
| Total Debt | $3.27B | $220M | $303M | $26.34B | $14.86B |
| Cash & Equiv. | $353M | $187M | $3.37B | $887M | $4.01B |
BYD vs PEN vs ISRG vs CZR vs SYK — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Boyd Gaming Corpora… (BYD) | 100 | 400.4 | +300.4% |
| Penumbra, Inc. (PEN) | 100 | 186.9 | +86.9% |
| Intuitive Surgical,… (ISRG) | 100 | 232.8 | +132.8% |
| Caesars Entertainme… (CZR) | 100 | 246.2 | +146.2% |
| Stryker Corporation (SYK) | 100 | 145.8 | +45.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BYD vs PEN vs ISRG vs CZR vs SYK
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BYD carries the broadest edge in this set and is the clearest fit for value and quality.
- Lower P/E (11.9x vs 43.3x)
- 45.0% margin vs CZR's -4.2%
- +21.2% vs SYK's -22.5%
- 27.9% ROA vs CZR's -1.5%, ROIC 12.3% vs 5.4%
PEN is the #2 pick in this set and the best alternative if growth exposure and sleep-well-at-night is your priority.
- Rev growth 17.5%, EPS growth 11.6%, 3Y rev CAGR 18.3%
- Lower volatility, beta 0.25, Low D/E 15.4%, current ratio 6.64x
- Beta 0.25 vs CZR's 1.27, lower leverage
ISRG ranks third and is worth considering specifically for long-term compounding.
- 5.5% 10Y total return vs BYD's 365.7%
- 20.5% revenue growth vs CZR's 2.1%
Among these 5 stocks, CZR doesn't own a clear edge in any measured category.
SYK is the clearest fit if your priority is income & stability and valuation efficiency.
- Dividend streak 34 yrs, beta 0.55, yield 1.1%
- PEG 1.32 vs ISRG's 1.99
- Beta 0.55, yield 1.1%, current ratio 1.89x
- 1.1% yield, 34-year raise streak, vs BYD's 0.8%, (3 stocks pay no dividend)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 20.5% revenue growth vs CZR's 2.1% | |
| Value | Lower P/E (11.9x vs 43.3x) | |
| Quality / Margins | 45.0% margin vs CZR's -4.2% | |
| Stability / Safety | Beta 0.25 vs CZR's 1.27, lower leverage | |
| Dividends | 1.1% yield, 34-year raise streak, vs BYD's 0.8%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +21.2% vs SYK's -22.5% | |
| Efficiency (ROA) | 27.9% ROA vs CZR's -1.5%, ROIC 12.3% vs 5.4% |
BYD vs PEN vs ISRG vs CZR vs SYK — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
BYD vs PEN vs ISRG vs CZR vs SYK — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ISRG leads in 3 of 6 categories
CZR leads 1 • SYK leads 1 • BYD leads 0 • PEN leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ISRG leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SYK is the larger business by revenue, generating $25.1B annually — 17.3x PEN's $1.5B. BYD is the more profitable business, keeping 45.0% of every revenue dollar as net income compared to CZR's -4.2%. On growth, ISRG holds the edge at +23.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $4.1B | $1.5B | $10.6B | $11.6B | $25.1B |
| EBITDAEarnings before interest/tax | $1.2B | $200M | $3.8B | $3.5B | $6.3B |
| Net IncomeAfter-tax profit | $1.8B | $171M | $3.0B | -$485M | $3.2B |
| Free Cash FlowCash after capex | $388M | $213M | $2.8B | $538M | $4.3B |
| Gross MarginGross profit ÷ Revenue | +42.1% | +67.4% | +66.3% | +43.9% | +63.5% |
| Operating MarginEBIT ÷ Revenue | +21.4% | +12.9% | +30.5% | +17.8% | +22.4% |
| Net MarginNet income ÷ Revenue | +45.0% | +11.8% | +28.2% | -4.2% | +12.9% |
| FCF MarginFCF ÷ Revenue | +9.5% | +14.6% | +26.8% | +4.7% | +17.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.0% | +15.6% | +23.0% | +2.7% | +11.4% |
| EPS Growth (YoY)Latest quarter vs prior year | -6.8% | -18.0% | +18.8% | +11.1% | +56.0% |
Valuation Metrics
CZR leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 3.8x trailing earnings, BYD trades at a 95% valuation discount to PEN's 71.8x P/E. Adjusting for growth (PEG ratio), SYK offers better value at 2.36x vs ISRG's 2.65x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $6.4B | $12.8B | $161.1B | $5.7B | $112.7B |
| Enterprise ValueMkt cap + debt − cash | $9.3B | $12.8B | $158.0B | $31.1B | $123.5B |
| Trailing P/EPrice ÷ TTM EPS | 3.78x | 71.82x | 57.62x | -11.48x | 35.03x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.93x | 65.17x | 43.35x | — | 19.62x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 2.65x | — | 2.36x |
| EV / EBITDAEnterprise value multiple | 7.91x | 61.91x | 43.62x | 8.90x | 20.31x |
| Price / SalesMarket cap ÷ Revenue | 1.57x | 9.09x | 16.00x | 0.49x | 4.49x |
| Price / BookPrice ÷ Book value/share | 2.67x | 8.93x | 9.17x | 1.57x | 5.02x |
| Price / FCFMarket cap ÷ FCF | 16.52x | 72.97x | 64.67x | 10.88x | 26.31x |
Profitability & Efficiency
ISRG leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
BYD delivers a 91.8% return on equity — every $100 of shareholder capital generates $92 in annual profit, vs $-13 for CZR. ISRG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to CZR's 7.15x. On the Piotroski fundamental quality scale (0–9), PEN scores 7/9 vs CZR's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +91.8% | +12.3% | +16.9% | -12.6% | +15.0% |
| ROA (TTM)Return on assets | +27.9% | +9.6% | +14.8% | -1.5% | +6.9% |
| ROICReturn on invested capital | +12.3% | +11.3% | +15.0% | +5.4% | +11.4% |
| ROCEReturn on capital employed | +15.1% | +12.5% | +16.5% | +7.0% | +13.0% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 | 6 | 5 | 6 |
| Debt / EquityFinancial leverage | 1.25x | 0.15x | 0.02x | 7.15x | 0.66x |
| Net DebtTotal debt minus cash | $2.9B | $33M | -$3.1B | $25.5B | $10.8B |
| Cash & Equiv.Liquid assets | $353M | $187M | $3.4B | $887M | $4.0B |
| Total DebtShort + long-term debt | $3.3B | $220M | $303M | $26.3B | $14.9B |
| Interest CoverageEBIT ÷ Interest expense | 15.78x | 304.65x | — | 0.90x | 6.72x |
Total Returns (Dividends Reinvested)
ISRG leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ISRG five years ago would be worth $15,873 today (with dividends reinvested), compared to $2,627 for CZR. Over the past 12 months, BYD leads with a +21.2% total return vs SYK's -22.5%. The 3-year compound annual growth rate (CAGR) favors ISRG at 14.4% vs CZR's -15.0% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -0.9% | +4.9% | -19.3% | +17.9% | -15.2% |
| 1-Year ReturnPast 12 months | +21.2% | +12.2% | -15.4% | +2.5% | -22.5% |
| 3-Year ReturnCumulative with dividends | +24.2% | +4.5% | +49.6% | -38.6% | +5.5% |
| 5-Year ReturnCumulative with dividends | +30.1% | +19.6% | +58.7% | -73.7% | +21.5% |
| 10-Year ReturnCumulative with dividends | +365.7% | +505.9% | +554.2% | +302.6% | +187.1% |
| CAGR (3Y)Annualised 3-year return | +7.5% | +1.5% | +14.4% | -15.0% | +1.8% |
Risk & Volatility
Evenly matched — BYD and PEN each lead in 1 of 2 comparable metrics.
Risk & Volatility
PEN is the less volatile stock with a 0.25 beta — it tends to amplify market swings less than CZR's 1.27 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BYD currently trades 94.7% from its 52-week high vs SYK's 72.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.84x | 0.23x | 1.00x | 1.24x | 0.52x |
| 52-Week HighHighest price in past year | $89.96 | $362.41 | $603.88 | $31.58 | $404.87 |
| 52-Week LowLowest price in past year | $69.01 | $221.26 | $427.84 | $17.95 | $289.91 |
| % of 52W HighCurrent price vs 52-week peak | +94.7% | +89.6% | +75.1% | +88.0% | +72.7% |
| RSI (14)Momentum oscillator 0–100 | 49.7 | 36.7 | 42.4 | 54.5 | 24.3 |
| Avg Volume (50D)Average daily shares traded | 932K | 544K | 1.8M | 4.6M | 2.1M |
Analyst Outlook
SYK leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: BYD as "Buy", PEN as "Hold", ISRG as "Buy", CZR as "Buy", SYK as "Buy". Consensus price targets imply 37.3% upside for ISRG (target: $623) vs 10.0% for CZR (target: $31). For income investors, SYK offers the higher dividend yield at 1.14% vs BYD's 0.84%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $95.00 | $371.92 | $622.60 | $30.57 | $403.69 |
| # AnalystsCovering analysts | 38 | 22 | 55 | 30 | 50 |
| Dividend YieldAnnual dividend ÷ price | +0.8% | — | — | — | +1.1% |
| Dividend StreakConsecutive years of raises | 4 | — | — | 0 | 34 |
| Dividend / ShareAnnual DPS | $0.71 | — | — | — | $3.36 |
| Buyback YieldShare repurchases ÷ mkt cap | +12.1% | 0.0% | +1.4% | +4.0% | 0.0% |
ISRG leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CZR leads in 1 (Valuation Metrics). 1 tied.
BYD vs PEN vs ISRG vs CZR vs SYK: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BYD or PEN or ISRG or CZR or SYK a better buy right now?
For growth investors, Intuitive Surgical, Inc.
(ISRG) is the stronger pick with 20. 5% revenue growth year-over-year, versus 2. 1% for Caesars Entertainment, Inc. (CZR). Boyd Gaming Corporation (BYD) offers the better valuation at 3. 8x trailing P/E (11. 9x forward), making it the more compelling value choice. Analysts rate Boyd Gaming Corporation (BYD) a "Buy" — based on 38 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BYD or PEN or ISRG or CZR or SYK?
On trailing P/E, Boyd Gaming Corporation (BYD) is the cheapest at 3.
8x versus Penumbra, Inc. at 71. 8x. On forward P/E, Boyd Gaming Corporation is actually cheaper at 11. 9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Stryker Corporation wins at 1. 32x versus Intuitive Surgical, Inc. 's 1. 99x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — BYD or PEN or ISRG or CZR or SYK?
Over the past 5 years, Intuitive Surgical, Inc.
(ISRG) delivered a total return of +58. 7%, compared to -73. 7% for Caesars Entertainment, Inc. (CZR). Over 10 years, the gap is even starker: ISRG returned +549. 2% versus SYK's +179. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BYD or PEN or ISRG or CZR or SYK?
By beta (market sensitivity over 5 years), Penumbra, Inc.
(PEN) is the lower-risk stock at 0. 23β versus Caesars Entertainment, Inc. 's 1. 24β — meaning CZR is approximately 440% more volatile than PEN relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 7% for Caesars Entertainment, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — BYD or PEN or ISRG or CZR or SYK?
By revenue growth (latest reported year), Intuitive Surgical, Inc.
(ISRG) is pulling ahead at 20. 5% versus 2. 1% for Caesars Entertainment, Inc. (CZR). On earnings-per-share growth, the picture is similar: Penumbra, Inc. grew EPS 1156% year-over-year, compared to -87. 6% for Caesars Entertainment, Inc.. Over a 3-year CAGR, PEN leads at 18. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BYD or PEN or ISRG or CZR or SYK?
Boyd Gaming Corporation (BYD) is the more profitable company, earning 45.
0% net margin versus -4. 4% for Caesars Entertainment, Inc. — meaning it keeps 45. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus 13. 5% for PEN. At the gross margin level — before operating expenses — PEN leads at 67. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BYD or PEN or ISRG or CZR or SYK more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Stryker Corporation (SYK) is the more undervalued stock at a PEG of 1. 32x versus Intuitive Surgical, Inc. 's 1. 99x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Boyd Gaming Corporation (BYD) trades at 11. 9x forward P/E versus 65. 2x for Penumbra, Inc. — 53. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ISRG: 37. 3% to $622. 60.
08Which pays a better dividend — BYD or PEN or ISRG or CZR or SYK?
In this comparison, SYK (1.
1% yield), BYD (0. 8% yield) pay a dividend. PEN, ISRG, CZR do not pay a meaningful dividend and should not be held primarily for income.
09Is BYD or PEN or ISRG or CZR or SYK better for a retirement portfolio?
For long-horizon retirement investors, Stryker Corporation (SYK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
52), 1. 1% yield, +179. 2% 10Y return). Both have compounded well over 10 years (SYK: +179. 2%, CZR: +306. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BYD and PEN and ISRG and CZR and SYK?
These companies operate in different sectors (BYD (Consumer Cyclical) and PEN (Healthcare) and ISRG (Healthcare) and CZR (Consumer Cyclical) and SYK (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: BYD is a small-cap deep-value stock; PEN is a mid-cap high-growth stock; ISRG is a mid-cap high-growth stock; CZR is a small-cap quality compounder stock; SYK is a mid-cap quality compounder stock. BYD, SYK pay a dividend while PEN, ISRG, CZR do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.